Both in Surgical Instruments
Nephros vs TELA Bio
Over the past year NEPH returned −37.5% and TELA returned −35.1%; their daily moves had a correlation of 0.06.
NEPH −37.5% TELA −35.1%Growth of $1, one year, split-adjusted
| Metric | NEPH | TELA |
|---|---|---|
| Price | $3.25 | $0.8378 |
| Market cap | $35.3M | $37.8M |
| Today | +0.31% | +4.46% |
| 1 month | +7.6% | −23.1% |
| 6 months | +0.9% | −15.4% |
| Year to date | −33.4% | −29.0% |
| 1 year | −39.5% | −38.8% |
| Revenue growth (YoY) | +36.2% | −4.5% |
| Gross margin | 66.9% | 72.3% |
| Net margin | 19.9% | −58.4% |
| P/E (TTM) | 20.3× | — |
| Price / sales | 1.7× | 0.5× |
| Net cash | $4.7M | -$25.7M |
| Dividend yield | — | — |
| Volatility (60d) | 72.5% | 85.7% |
| Short % of float | 0.2% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).